Daraprim is the Media Catalyst for the Drug Price Narrative

By on March 11, 2016 in Condition and Disease Trends, Pharmaceutical Brands, Prescription Drug Brands

Tags: , , ,

Comments Off on Daraprim is the Media Catalyst for the Drug Price Narrative

Daraprim sparked a media storm around drug pricing practices. From legislative hearings to actual pressure to reduce Medicaid pricing for specialty drugs, the media attention on Turing Pharmaceuticals may have led to some real market changes.